+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Factors associated with fear of lymphedema after treatment for breast cancer



Factors associated with fear of lymphedema after treatment for breast cancer



Oncology Nursing Forum 41(5): 473-483



To identify demographic and treatment characteristics associated with postoperative fear of lymphedema. Prospective cohort study. Outpatient breast clinic at a comprehensive cancer center in the northeastern United States. 324 patients undergoing treatment for unilateral breast cancer. Women with breast cancer were prospectively screened for lymphedema (relative volume change of 10% or greater) preoperatively and every three to eight months postoperatively via Perometer arm volume measurements. Fear was simultaneously evaluated via questionnaire. Multivariate linear mixed-effects regression models were used to identify factors associated with mean postoperative fear score and to plot the average fear score over time within axillary surgery type subgroups. Postoperative fear of lymphedema. Higher preoperative fear score (p < 0.0001), younger age at diagnosis (p = 0.0038), and axillary lymph node dissection (ALND) (p < 0.0001) were significantly associated with higher mean postoperative fear score. The average fear score changed nonlinearly over time (p < 0.0001), decreasing from preoperative to 24 months postoperative and leveling thereafter. Preoperative fear, younger age at diagnosis, and ALND may contribute to postoperative fear of lymphedema. Individualized education that begins preoperatively, continues throughout treatment, and is re-emphasized 24 months postoperatively may help minimize fear of lymphedema.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 053193127

Download citation: RISBibTeXText

PMID: 25158653

DOI: 10.1188/14.onf.473-483


Related references

Time-course of arm lymphedema and potential risk factors for progression of lymphedema after breast conservation treatment for early stage breast cancer. Breast Journal 18(3): 219-225, 2012

Factors influencing response to lymphedema treatment in patients with breast cancer-related lymphedema. Supportive Care in Cancer 23(9): 2705-2710, 2015

Complaints made to the GMC. Bmj 361: K2650, 2018

Treatment factors affecting breast cancer-related lymphedema after systemic chemotherapy and radiotherapy in stage II/III breast cancer patients. Breast Cancer Research and Treatment 148(1): 91-98, 2014

Risk factors for lymphedema after breast cancer treatment. Cancer Epidemiology Biomarkers and Prevention 19(11): 2734-2746, 2010

Are hemodynamic factors important in arm lymphedema after treatment of breast cancer?. Lymphology 29(4): 155-157, 1996

Effectiveness of Decongestive Lymphatic Therapy in Patients with Lymphedema Resulting from Breast Cancer Treatment Regardless of Previous Lymphedema Treatment. Breast Journal 23(2): 154-158, 2017

The incidence and risk factors for occurrence of arm lymphedema after treatment of breast cancer. Chirurgia 110(1): 33-37, 2015

Prevalence and risk factors for development of lymphedema following breast cancer treatment. Indian Journal of Cancer 41(1): 8, 2004

The efficacy of complex decongestive physiotherapy (CDP) and predictive factors of lymphedema severity and response to CDP in breast cancer-related lymphedema (BCRL). Breast 22(5): 703-706, 2013

Risk factors for developing upper limb lymphedema after breast cancer treatment. Bulletin du Cancer 93(10): 1001-1006, 2006

Barcelona Lymphedema Algorithm for Surgical Treatment in Breast Cancer-Related Lymphedema. Journal of Reconstructive Microsurgery 32(5): 329-335, 2016

Treatment of lymphedema with pulsator. How to help patients with lymphedema following breast cancer operations. Tidsskrift for den Norske Laegeforening 103(24): 1697-1698, 1983

Treatment-related risk factors for arm lymphedema among long-term breast cancer survivors. Journal of Cancer Survivorship 9(3): 422-430, 2015

The risk of developing arm lymphedema among breast cancer survivors: a meta-analysis of treatment factors. Annals of Surgical Oncology 16(7): 1959-1972, 2009